Modified personalized cancer vaccine generates powerful immune response

Published Date: 11 Jul 2025

Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax personalized cancer vaccine called NeoVaxMI is safe, feasible, ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Research uncovers hidden Australian skin cancer epidemic

2.

Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity

3.

Reasons Behind Refusing Stem Cell Transplantation in Certain Myeloma Patients.

4.

Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer

5.

Short-course radiation matches standard therapy for endometrial cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot